Cetera Advisor Networks’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
PA
KCM
KCM
EAM
Cetera Advisor Networks's ALDX Position: Q1 2024 in Review
Cetera Advisor Networks increased its Aldeyra Therapeutics (ALDX) stake by 4% in Q1 2024, buying an estimated $1.92K and bringing the position to 15,177 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2743.
Cetera Advisor Networks first reported a position in ALDX in Q3 2020 and has held it in 13 quarters since. The position peaked at $143K in Q1 2023. 102 funds tracked by Wall St. Rank hold ALDX as of Q1 2024.
- Cetera Advisor Networks held 15,177 shares of Aldeyra Therapeutics worth $49.6K as of Q1 2024.
- Cetera Advisor Networks bought 583 Aldeyra Therapeutics shares in Q1 2024, an estimated $1.92K.
- Aldeyra Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2743 holding.
- Cetera Advisor Networks first reported a position in Aldeyra Therapeutics in Q3 2020 and has held it in 13 quarters since.
- Cetera Advisor Networks's Aldeyra Therapeutics position peaked at $143K in Q1 2023.
- 102 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2024.
Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.